Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.27 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.27, with a volume of 3,451,659 shares trading hands.
Northwest Biotherapeutics Stock Performance
The stock has a market cap of $394.59 million, a price-to-earnings ratio of -3.40 and a beta of -1.09. The business's 50 day moving average is $0.27 and its 200 day moving average is $0.27.
Northwest Biotherapeutics (OTCMKTS:NWBO - Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The biotechnology company reported ($0.01) EPS for the quarter. The business had revenue of $0.38 million during the quarter.
Northwest Biotherapeutics Company Profile
(
Get Free Report)
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
See Also
Before you consider Northwest Biotherapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Northwest Biotherapeutics wasn't on the list.
While Northwest Biotherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
